Trials / Conditions / Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
4 registered clinical trials studyying Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combinat NCT06726265 | Immutep S.A.S. | Phase 3 |
| Not Yet Recruiting | PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) NCT06590194 | Suzhou Puhe Pharmaceutical Technology Co., LTD | Phase 1 / Phase 2 |
| Not Yet Recruiting | YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With NCT05767892 | Suzhou Puhe Pharmaceutical Technology Co., LTD | Phase 3 |
| Active Not Recruiting | TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With NCT04129502 | Takeda | Phase 3 |